宫颈细胞学检查200例临床资料分析
|
摘要
目的分析与宫颈上皮内瘤样变(cervical Intraepithelial Neoplasia CIN)发生的相关因素与危险因素,探讨降低传统宫颈刮片漏诊率的策略,寻找本地区宫颈癌筛查的有效途径。方法对宁夏医科大学附属医院妇科2007年1月-2008年10月经宫颈刮片检查诊断为巴氏II级[1]200例患者的临床资料进行分析,用Logistic回归、卡方检验、t检验对数据进行分析。结果(1)200例巴氏II级患者中炎症143例,CINⅠ28例,CINⅡ18例,CINⅢ9例(包括原位癌4例),宫颈癌2例,假阴性率为28.5%。(2)Logistic回归分析得出CIN、宫颈癌与患者年龄、初次性生活年龄、患者所处地区具有相关性(P<0.05)。(3)初次性生活年龄在≥25岁与≤20岁的患者CIN、宫颈癌发生率具有显著不同(P<0.05)。(4)阴道异常出血患者CIN、宫颈癌发生率在各种主诉中比例最高,为40%,且不同年龄段发生有差别,具有统计学意义(P<0.05),其中年龄在35-44岁的患者发生率最高,为55%。(5)CIN、宫颈癌在宁夏各周边地区发生率不同,具有统计学意义(P<0.05),其中固原地区发病率最高,为52.4%。(6)从未做过宫颈刮片检查的患者CIN的发生率较做过宫颈刮片检查的明显升高(χ2=14.33,P<0.01)。(7)80例患者行TCT检查,TCT对CIN诊断的敏感性为81.0%(17/21),特异性为88.1%(52/59),阳性预测值为70.8% (17/24),阴性预测值为88.1% (52/59)。TCT检查的阳性率为30.0%(24/80),病理组织学阳性率为26.3%(21/80),二者相比无显著性差异(χ2=0.261,P>0.05)。TCT与病理总符合率为86.3%(69/80),宫颈刮片与病理组织学符合率为73.8%(59/80),二者差别有统计学意义(P<0.05)。(8)65例行HC2检测,HPV阳性者CIN的发生率为81.8%,HPV阴性者CIN的发生率为18.6%,HPV阳性者CIN发生率明显升高,二者相比有统计学意义(P<0.05)。(9)TCT与HC2联合检查者38例,细胞学与HPV检查均阴性者CIN检出率为6.3%,细胞学与HPV检查均阳性者CIN检出率为77.8%,二者均阴性的CIN的检出率显著低于二者均阳性的CIN的检出率,二者相比有统计学意义(P<0.05)。结论(1)宫颈刮片检查有一定的假阴性率,但在本地区宫颈刮片仍然是行之有效的方法而在临床广泛使用。(2)妇科医生要重视CIN、宫颈癌发生的相关因素及患者的临床表现,是提高CIN、宫颈癌诊断率,弥补宫颈刮片假阴性率的重要环节。(3)液基细胞学检查敏感度、特异度均较高,是一种较好的筛查方法,应该在临床推广使用,但是要提高取材质量及诊断水平。(4)HPV-DNA检测与宫颈刮片结合用于宫颈癌的筛查,可以降低宫颈刮片的假阴性率,是宫颈刮片的重要补充。(5)TCT联合HC2是理想的筛查方案但由于价格高,难以在经济欠发达地区普遍应用。
Objective Analysis of the related factors and risk factors in the occurrence of cervical Intraepithelial Neoplasia (CIN), in order to explore the strategy of reducing the rate of missed diagnosis in conventional Pap smears, looking for an effective way in cervical cancer screening in this region.Methods 200 cases come from department of gynecology Pap smear diagnosed as Pap II in the affilliated to Ningxia Medical University during July 2007 to October 2008 were analyzed with logistic regression,Chisquar test,t test. Results (1) 200 cases pathologically diagnosed as cervicitis 143 cases, CINⅠ28 cases, CINⅡ18 cases, CINⅢ9 cases(Including carcinoma in situ 4 cases), carcinoma 2 cases, false negative rate was 28.5%. (2) Lgistic regression analysis showed the correlative factors for CIN include age,age of initial sexual life,the region of patients. The strongest risk factors was age of initial sexual life (OR=15.57). (3) The incidence of CIN,cervical cancer was statistical significance in age of initial sexual life between≥25 years old and≤20-year-old (P<0.05). (4) The highest incidence rate of CIN,cervical cancer in all complait was abnormal vaginal bleeding, the rate was 40%, there was statistical significance in different age groups (P<0.05), the highest rate was 35-44 years old, the rate was 55%. (5)The incidence of CIN,cervical cancer was different with statistical significance in the Ningxia region and it’s surrounding areas(P<0.05), the highest incidence is Guyuan region, the rate is 52.4%. (6)The incidence of CIN,ceivcal cancer was significantly higher in patients who had never been deteced by Pap smear, there was statistical significance comparing to those who had detected by Pap smear (χ2=14.33,P<0.01). (7) 80 cases had been checked by Liquid based Cytology Testing (TCT), thesensitivity of TCT diagnosis of CIN was 81.0%, the specificity was 8.1%(52/59), positive predictive value was 70.8% (17/24), negative predictive value was 88.1% (52/59), the positive rate of TCT detection was 30.0%(24/80),the positive rate of pathological histology detection was 26.3%(21/80), difference did not exist statistical significance (χ2=0.261, P>0.05). The total coincidence between TCT and pathological histology was 86.3% (69/80), the total coincidence between Pap smear and pathological histology was 73.8% (59/80), difference existed statistical significance (P<0.05). (8) 65 cases had been checked by Hybrid Capture2 (HC2 ), the incidence of CIN in HPV-positive was 81.8%, the incidence in HPV-negative was 18.6%, the incidence of CIN in HPV-positive was significantly higher than in HPV-negative, difference exist statistical significance (P<0.05). (9) Combined use of TCT and HC2, the detection rate of CIN was 6.3% when two value were negative, and the rate was 77.8% when two value were positive, there was statistical significance. (P<0.05). Conclusion (1) Pap smear has the false negative rate, but in this region it is a well-established method widely used in clinical. (2)Attention should be paid to related factors of CIN,cervical cancer and patients’clinical manifestations by gynecologist, which is important part to improve the rate of CIN,cancer diagnosis and make up for false-negative rate of conventional Pap smears. (3) The sensitivity and specificity of Liquid-based Cytology are high, it has a greater advantage compared to conventional Pap smears(CPS), it is a better screening methods should be promoted in clinic, but should raise the level of specimens quality and the diagnosis level. (4) The combined use of HC2 and Pap smear for cervical cancer screening can reduce the false negative rate of Pap smear, is an important supplement for Pap smear. (5) The combined use of Liquid based Cytology and HC2 testing is more efficient to detect cervical cancer, but as a result of high prices, it is difficult to use generally in economically underdeveloped areas.
Objective Analysis of the related factors and risk factors in the occurrence of cervical Intraepithelial Neoplasia (CIN), in order to explore the strategy of reducing the rate of missed diagnosis in conventional Pap smears, looking for an effective way in cervical cancer screening in this region.Methods 200 cases come from department of gynecology Pap smear diagnosed as Pap II in the affilliated to Ningxia Medical University during July 2007 to October 2008 were analyzed with logistic regression,Chisquar test,t test. Results (1) 200 cases pathologically diagnosed as cervicitis 143 cases, CINⅠ28 cases, CINⅡ18 cases, CINⅢ9 cases(Including carcinoma in situ 4 cases), carcinoma 2 cases, false negative rate was 28.5%. (2) Lgistic regression analysis showed the correlative factors for CIN include age,age of initial sexual life,the region of patients. The strongest risk factors was age of initial sexual life (OR=15.57). (3) The incidence of CIN,cervical cancer was statistical significance in age of initial sexual life between≥25 years old and≤20-year-old (P<0.05). (4) The highest incidence rate of CIN,cervical cancer in all complait was abnormal vaginal bleeding, the rate was 40%, there was statistical significance in different age groups (P<0.05), the highest rate was 35-44 years old, the rate was 55%. (5)The incidence of CIN,cervical cancer was different with statistical significance in the Ningxia region and it’s surrounding areas(P<0.05), the highest incidence is Guyuan region, the rate is 52.4%. (6)The incidence of CIN,ceivcal cancer was significantly higher in patients who had never been deteced by Pap smear, there was statistical significance comparing to those who had detected by Pap smear (χ2=14.33,P<0.01). (7) 80 cases had been checked by Liquid based Cytology Testing (TCT), thesensitivity of TCT diagnosis of CIN was 81.0%, the specificity was 8.1%(52/59), positive predictive value was 70.8% (17/24), negative predictive value was 88.1% (52/59), the positive rate of TCT detection was 30.0%(24/80),the positive rate of pathological histology detection was 26.3%(21/80), difference did not exist statistical significance (χ2=0.261, P>0.05). The total coincidence between TCT and pathological histology was 86.3% (69/80), the total coincidence between Pap smear and pathological histology was 73.8% (59/80), difference existed statistical significance (P<0.05). (8) 65 cases had been checked by Hybrid Capture2 (HC2 ), the incidence of CIN in HPV-positive was 81.8%, the incidence in HPV-negative was 18.6%, the incidence of CIN in HPV-positive was significantly higher than in HPV-negative, difference exist statistical significance (P<0.05). (9) Combined use of TCT and HC2, the detection rate of CIN was 6.3% when two value were negative, and the rate was 77.8% when two value were positive, there was statistical significance. (P<0.05). Conclusion (1) Pap smear has the false negative rate, but in this region it is a well-established method widely used in clinical. (2)Attention should be paid to related factors of CIN,cervical cancer and patients’clinical manifestations by gynecologist, which is important part to improve the rate of CIN,cancer diagnosis and make up for false-negative rate of conventional Pap smears. (3) The sensitivity and specificity of Liquid-based Cytology are high, it has a greater advantage compared to conventional Pap smears(CPS), it is a better screening methods should be promoted in clinic, but should raise the level of specimens quality and the diagnosis level. (4) The combined use of HC2 and Pap smear for cervical cancer screening can reduce the false negative rate of Pap smear, is an important supplement for Pap smear. (5) The combined use of Liquid based Cytology and HC2 testing is more efficient to detect cervical cancer, but as a result of high prices, it is difficult to use generally in economically underdeveloped areas.
引文
[1]刘树范,浅析巴氏五级分类法与TBS描述性诊断报告方式,中国实用妇科和产科杂志, 2003, 19(3): 135.
[2] Ftcutts, Sfranceschi, Sgoldie, Xcastellsague, Sdesanjose, Ggarnett, Wjedmunds, P Claeys. Human papillomavirus and HPV vaccines.Bulletin of the World Health Organization, 2007 September, 85(9): 719-726.
[3]王金桃,高尔生. HPV感染与宫分析颈癌关系研究进展.国外医学妇幼保健分册, 2003, 14(6): 399-403.
[4]丁峰,丘娜璇,许雅云,宫颈涂片提示炎症963例与阴道镜下宫颈活检结果对比分析,福建医药杂志, 2005, 27(6): 24.
[5] C. Patel, A. Ullal, M. Roberts, J. Brady, P. Birch, J. N. Bulmerand V. Wadehra,Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology,cytopathology, 21 Jan 2009, 122.
[6]郎景和.迎接子宫颈癌预防的全球挑战与机遇,中华妇产科杂志, 2002, 3, 37(3): 129
[7] Carolyn D. Runowicz, M. D. Molecular Screening for cervical cancer time to give up Pap tests? The new Egland and journal of medicinen October, 2007(18): 1651-1652.
[8] Anttila A, Pukkala E, Soderman B, et al. Effect of organized screening on cervical cancer incident and mortality in filand, 1963-1995: recent incease in cervcal cancer incident. Intjancer 1999, 83: 59-65.
[9]潘秦镜,李凌,乔有林等.液基细胞学筛查宫颈癌的研究.中华肿瘤杂志, 2001, 23(4): 309-312.
[10] Aldx Ferenczy, Eduardo Franco.Cervical-cancer screenning beyond the year 2000. lancel oncol. 2001, 2: 27-32.
[11] Savage EW, Chapman G. Cervical dysplasia and cancer. In: Hacker NF, Moore JG.Essentials of Obstetrics and Gynecology. 3rd ed. Philadelphia: Saunders, 1998. 645.
[12]丁峰,丘娜璇,许雅云,宫颈涂片提示炎症963例与阴道镜下宫颈活检结果对比分析,福建医药杂志, 2005, 27(6): 24.
[13]高尔生,武俊青,张军,生殖健康流行病学研究方法,上海医科大学出版社, 1998. 1-6.
[14]李庭芳,陈锐,宫颈癌临床流行病学概述,实用医院临床杂志, 2005, 2(2): 19.
[15] Boyle P, Vecchia C, Walker A, et al. FIGO annual report on the results of treatment in gynecological Cancer [J]. Journal of epidemiology and biostatictcs, 2001, 12: 7-43.
[16] Liu J, Rose B, Huang X, et al. Comparative analysis of characteristics of women with cervical cancer in high-versus low-incidence regions [J]. GynecolOncol, 2004, 94(3): 803-810.
[17]郝敏,王静芳,宫颈癌流行病学研究与调查,国外医学妇幼保健分册, 2005, 16(6): 404-405
[18] Doudja Hammouda, Nubia Muiioz, Rolanda Herrero. cervical carcinoma in Algiers, human papillomavirus and lifestyle risk factors[J]. Int JCancer, 2005, 113(3): 483-489.
[19] Silvi Franceschi, Thangarajan, Rajuma, Salvatore, Vaccarella. Human papilloma vir us and risk factors for cervical cancer in Chennai India:a case-control study [J]. Int JCancer, 2003, 107(1): 127-133.
[20] BRostad, Bschei, Fdacosta, Risk factors for cervical cancer in Mozambican women[J]. Gynecology obstetrics, 2003, 80(1): 63-65.
[21] Fang-hui Zhao, Michele RForman, JeomeBelinson. Risk factors for HPV infection and cervical cancer among unscreened women in high-risk rural area of China [J]. Int Jcancer, 2006, 118(2): 442-448.
[22] Michelle J, Khan, Edward E, Partridge, Sophia S Wang. Socio economic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillo-mavirus DNA-positive women with equivocal or mildly abnormal cytology [J]. Cancer, 2005, 104(1): 61-70.
[23]李隆玉,曾四元,乔志强等.宫颈癌?宫颈上皮内瘤变的高危因素研究进展[J].中国肿瘤, 2007, 16(5): 320-322.
[24]邱锐,凌玫,马娅芬,雷彦,莫兰凤.健康教育对宫颈糜烂妇女治疗依从性的研究,Anthology of Medicine, Dec. 2004. Vol. 23. No. 6: 706
[25]俞顺章.子宫颈癌危险因素的流行病学研究[J].实用肿瘤杂志, 1998, 13(3): 138-140.
[26] Velema J P, Ferrer A, Figueroa M, et al. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras [J]. Int JCancer, 2002, 97(4): 536-541.
[27] Schiff M, Miller J, Masuk M, et al. Contraceptive and reproductive risk factors of cervical intraepithelial neoplasia in America Indian women [J]. Int JEpidemiol, 2000, 29: 983-990.
[28]汤惠茹,乌兰娜,刘志红等.子宫颈上皮内瘤变患者高危因素分析[J].中华妇产科杂志, 2006, 41(8): 564-566.
[29] Becker TM, Wheeler CM, McGough NS, et al. Contraceptive and reproductive risks for cervical dysplasia in southwestern. Hispanic and non-Hispanic White women [J]. Int JEpidemiol, 1994, 23: 913-922.
[30] Smith JS, Green J, BerringtonG A, et al. Cervical cancerand use of hormonal contraceptives: a systematic review [J]. Lancet, 2003, 361: 1159-1167.
[31] Paer A, Bayatpour M, Paer MM, Oncogenic transformation of human papilloma virus type deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptive. Am J Obstet Gynecol, 1990, 162: 1009-103.
[32] Auborn KJ, Woodworth C, DiPaolo JA, Bradlow HL. The interaction between HPVestrogen metabolism in cervical carcinogensis.Int J Cancer 1991, 49: 857-67.
[33] Lassise DH, savitz DA, Hamman RF, Baron AE, Barnton LA, Levines RS. Invasion cervical cancer and intrauterine device use. Int J Epidemiol 1991, 20: 865-70.
[34]杜丽敏,王玉荣,陆春雪,洪春艳.性交后出血与病理学异常的关系探讨.中国实用妇科和产科杂志. 2003, 19(6): 343-344.
[35] deSouza NM, Soutter WP, McIndoe GA, et al. StageⅠcervical cancer:tumor volume by magnetic resonance imaging of screen-detected versus symptomatic lesions. J Natl Cancer Inst, 1997, 89: 131.
[36]高娜.传统巴氏涂片法、液基制片法及HPV-DNA检测法筛查宫颈癌及癌前病变的比较研究. 2004中国优秀硕士论文: 12-13.
[37] Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women·Br JCancer, 2001, 84: 1616-1623.
[38] Blumenthal PD, Gaffikin L, Chirenje ZM, et al. Adjunctive testingfor cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int Jgynaecol Obstet, 2001, 72: 47-53.
[39]杨钦灵.宫颈刮片联合人乳头瘤病毒检测在诊断子宫颈疾病中的应用,临床和实用医学杂志,2006, 5(9): 1281.
[40] Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papilloma virus testing, and risk for cervical neoplasia: a 10-year cohort analysis. JNatlCancer Inst, 2003, 95: 46-52.
[41] Schletcht. NF, Platt RW, Duarte E, et al. Human, papapilloma, virus infection and time to, progression and regression of cervical intraepithelia neoplasiaJ-Natl-Cancer-Ist, 2003, 95: 1336-1343.
[42] Agorastos T, Dinas K, Llove B, et al. Human papilloma-virus testing for primaryscreening in woman at low risk of developing cervical cancer [J]. Gynecolgic Oncology, 2005, 96(3): 714-720.
[43]牛淑芳,吴素慧.人乳头瘤病毒检测的研究进展[J].实用肿瘤学杂志, 2006, 82: 143-145.
[44]刘树范,冼美生,宫颈及阴道细胞病理学诊断报告方式的建议, Chin J Obstet Gynecl. May 1998. Vol 33. No 5:316.
[1] Douglas R, Lowy and John T, Schiller. Prophlactic human papilloma vaccines,The Journal of Clinical Investigation. 2006 May, 116(5): 1167-1173.
[2] Ftcutts S, Franceschi S, Goldie X, Castellsague, Sdesanjose, Ggarnett, Wjedmunds, P Claeys. Human Papillomavirus and HPV Vaccines, Bulletin of the World Health Organization. 2007 September, 85(9): 719-726.
[3] Bishop A, Sherris J, Tsu V. Cervical dysplasia treatmentpractices in developing countries: A situational analysis.Seattle(WA): Program for Appropriate Technology in Health (PATH), 1995.
[4] Wallboomers, JMM, Meijer, CHLM. Do, HPV-negative cervical carcinomasexist? J Pathol. 1997, 181: 253-254.
[5]王金桃,高尔生. HPV感染与宫颈癌关系研究进展,国外医学妇幼保健分册. 2003, 14(6): 399-403.
[6]詹姆斯,主编(James DK).高危妊娠处置的选择,第二版,北京科学出版社. 2001, 506.
[7] H.S.Cronje Screening for cervical cancer in developing countries, International Journal of Gynecology and Obstetrics 2004, 84: 101-108
[8] Carolyn D, Runowicz, M. D, Molecular Screening for Cervical Cancer time to Give up Pap Tests? The new Egland and journal of medicinen October, 2007(18): 1651-1652.
[9]刘树范,浅析巴氏五级分类法与TBS描述性诊断报告方式,中国实用妇科和产科杂志2003, 19(3): 135.
[10]沈艳红,乔友林.宫颈癌筛查方法的研究进展,国外医学情报, 2007, 22(7): 2-3, 14.
[11]潘秦镜,李凌,乔有林等.液基细胞学筛查宫颈癌的研究,中华肿瘤杂志. 2001, 23(4): 309-312.
[12] Aldx Ferenczy, Eduardo Franco, Cervical-cancer screenning beyond the year 2000,lancel oncol, 2001, 2: 27-32
[13]高琼,吴伟民,莫益欢,等.宫颈刮片、阴道镜及HPV检测在宫颈癌筛查中的体会,吉林医学2006, 27(7): 755.
[14]丁峰,丘娜璇,许雅云.宫颈涂片提示炎症963例与阴道镜下宫颈活检结果对比分析,福建医药杂志. 2005, 27(6): 24.
[15]田亚丽,于黎明,赵俊杰,等.宫颈病变检查413例临床分析,宁夏医学院学报,2008, 30(3): 333.
[16]杜丽敏,王玉荣,陆春雪,等.性交后出血与病理学异常的关系,探讨中国实用妇科和产科杂志, 2003, 19(6): 343-344.
[17] deSouza NM, Soutter WP, Mcndoe GA, et al. StageⅠcervical cancer tumor volume by magnetic resonance imaging of screen-detected versus symptomatic lesions, J Natl Cancer Inst, 1997, 89: 1314.
[18] Fraser IS, Petrucco OM. Management of intermenstrual and post-coital bleeding and an appreciation of the issues arising out of therecent case of O’shea versus Sullivan and Macqurie pathology. AustN Z J Obstet Gynecol. 1996, 36: 67.
[19]陈碧霞. 216例绝经后阴道出血原因分析,黔南民族医专学报. 2006, 19(4): 203-205.
[20]山东省人民医院,中国人民解放军九一医院,山东医学院附属医院主编,实用妇科学,山东科学技术出版社. 1980, 504.
[21] Castle, Philip E. Beyond human papillomavirus, the cervix, exogenous secondary factors, and the development of cervical precancer and cancer [J]. The American Society for Colposcopy and CervicalPathology. 2004, 8(3): 224-230.
[22]杜丽敏,陆春雪,赵巍.宫颈糜烂267例肉眼所见与病理诊断结果对比分析,中国现代医学杂志. 2006, 16(18): 2807-2808.
[23] Liu J, Rose B, Huang X, et al. Comparative analysis ofcharacteristics of women with cervical cancer in high-versus low-incidence regions [J]. GynecolOnco, 2004, 94(3): 803-810.
[24] Torres LA, Rojo HG, Torres RA, et al. Cervical cancer current view of its epidemiology and risk factors [J]. Gyneco lObstet Mex. 2004, 72: 466-474.
[25]连利娟.林巧稚妇科肿瘤学[M].第三版.北京:人民卫生出版社. 2000, 246-247.
[26] Velema JP, Ferrer A, Figueroa M, et al. Burning wood in the kitchen increasesthe risk of cervical neoplasia in HPV-infected women inHonduras [J]. Int JCancer, 2002, 97(4): 536-541.
[27]石一复.子宫颈疾病[M].北京:人民卫生出版社. 2000, 134-135.
[28] Smith JS, Green J, Berrington GA, et al. Cervical cancerand use of hormonal contraceptives: a systematic review [J]. Lancet, 2003, 361: 1159-1167.
[29] Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection, the IARC multicentric case control study [J]. Lancet, 2002, 359: 1085-1092.
[30]苑丹丹, HPV感染与宫颈癌相关研究进展.内蒙古医学杂志. 2007, 39(8): 957-960.
[31] Kevin A, Ault, Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract, infectious Diseasesin Obstetrics and Gynecology. 2006, 40470: 1-5.
[32] Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected,acase-control study nested within the Mancheste cohort, Br J Cancer. 2000, 88(11): 1565-1572.
[33] Georgette DA, TheresaFW, Human papillomavirua and cervical scereening, Curr Opin Obstet Gynecol. 2003, 15: 473-477.
[34]章文华主编.子宫颈病变的诊断要点,人民卫生出版社. 2006, 12(1).
[35] Oikawa K,Ohbayashi T, Kiyono T, et al. Expression of a novel human gene, human wings apart-like(Hwapl), is associated with cercical carcinogens antumor progression, Cancer Res. 2004, 64(5): 3545-3549.
[36]郎景和.迎接子宫癌预防的全球挑战与机遇,中华妇产科杂志. 2002, 37: 1291.
[2] Ftcutts, Sfranceschi, Sgoldie, Xcastellsague, Sdesanjose, Ggarnett, Wjedmunds, P Claeys. Human papillomavirus and HPV vaccines.Bulletin of the World Health Organization, 2007 September, 85(9): 719-726.
[3]王金桃,高尔生. HPV感染与宫分析颈癌关系研究进展.国外医学妇幼保健分册, 2003, 14(6): 399-403.
[4]丁峰,丘娜璇,许雅云,宫颈涂片提示炎症963例与阴道镜下宫颈活检结果对比分析,福建医药杂志, 2005, 27(6): 24.
[5] C. Patel, A. Ullal, M. Roberts, J. Brady, P. Birch, J. N. Bulmerand V. Wadehra,Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology,cytopathology, 21 Jan 2009, 122.
[6]郎景和.迎接子宫颈癌预防的全球挑战与机遇,中华妇产科杂志, 2002, 3, 37(3): 129
[7] Carolyn D. Runowicz, M. D. Molecular Screening for cervical cancer time to give up Pap tests? The new Egland and journal of medicinen October, 2007(18): 1651-1652.
[8] Anttila A, Pukkala E, Soderman B, et al. Effect of organized screening on cervical cancer incident and mortality in filand, 1963-1995: recent incease in cervcal cancer incident. Intjancer 1999, 83: 59-65.
[9]潘秦镜,李凌,乔有林等.液基细胞学筛查宫颈癌的研究.中华肿瘤杂志, 2001, 23(4): 309-312.
[10] Aldx Ferenczy, Eduardo Franco.Cervical-cancer screenning beyond the year 2000. lancel oncol. 2001, 2: 27-32.
[11] Savage EW, Chapman G. Cervical dysplasia and cancer. In: Hacker NF, Moore JG.Essentials of Obstetrics and Gynecology. 3rd ed. Philadelphia: Saunders, 1998. 645.
[12]丁峰,丘娜璇,许雅云,宫颈涂片提示炎症963例与阴道镜下宫颈活检结果对比分析,福建医药杂志, 2005, 27(6): 24.
[13]高尔生,武俊青,张军,生殖健康流行病学研究方法,上海医科大学出版社, 1998. 1-6.
[14]李庭芳,陈锐,宫颈癌临床流行病学概述,实用医院临床杂志, 2005, 2(2): 19.
[15] Boyle P, Vecchia C, Walker A, et al. FIGO annual report on the results of treatment in gynecological Cancer [J]. Journal of epidemiology and biostatictcs, 2001, 12: 7-43.
[16] Liu J, Rose B, Huang X, et al. Comparative analysis of characteristics of women with cervical cancer in high-versus low-incidence regions [J]. GynecolOncol, 2004, 94(3): 803-810.
[17]郝敏,王静芳,宫颈癌流行病学研究与调查,国外医学妇幼保健分册, 2005, 16(6): 404-405
[18] Doudja Hammouda, Nubia Muiioz, Rolanda Herrero. cervical carcinoma in Algiers, human papillomavirus and lifestyle risk factors[J]. Int JCancer, 2005, 113(3): 483-489.
[19] Silvi Franceschi, Thangarajan, Rajuma, Salvatore, Vaccarella. Human papilloma vir us and risk factors for cervical cancer in Chennai India:a case-control study [J]. Int JCancer, 2003, 107(1): 127-133.
[20] BRostad, Bschei, Fdacosta, Risk factors for cervical cancer in Mozambican women[J]. Gynecology obstetrics, 2003, 80(1): 63-65.
[21] Fang-hui Zhao, Michele RForman, JeomeBelinson. Risk factors for HPV infection and cervical cancer among unscreened women in high-risk rural area of China [J]. Int Jcancer, 2006, 118(2): 442-448.
[22] Michelle J, Khan, Edward E, Partridge, Sophia S Wang. Socio economic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillo-mavirus DNA-positive women with equivocal or mildly abnormal cytology [J]. Cancer, 2005, 104(1): 61-70.
[23]李隆玉,曾四元,乔志强等.宫颈癌?宫颈上皮内瘤变的高危因素研究进展[J].中国肿瘤, 2007, 16(5): 320-322.
[24]邱锐,凌玫,马娅芬,雷彦,莫兰凤.健康教育对宫颈糜烂妇女治疗依从性的研究,Anthology of Medicine, Dec. 2004. Vol. 23. No. 6: 706
[25]俞顺章.子宫颈癌危险因素的流行病学研究[J].实用肿瘤杂志, 1998, 13(3): 138-140.
[26] Velema J P, Ferrer A, Figueroa M, et al. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras [J]. Int JCancer, 2002, 97(4): 536-541.
[27] Schiff M, Miller J, Masuk M, et al. Contraceptive and reproductive risk factors of cervical intraepithelial neoplasia in America Indian women [J]. Int JEpidemiol, 2000, 29: 983-990.
[28]汤惠茹,乌兰娜,刘志红等.子宫颈上皮内瘤变患者高危因素分析[J].中华妇产科杂志, 2006, 41(8): 564-566.
[29] Becker TM, Wheeler CM, McGough NS, et al. Contraceptive and reproductive risks for cervical dysplasia in southwestern. Hispanic and non-Hispanic White women [J]. Int JEpidemiol, 1994, 23: 913-922.
[30] Smith JS, Green J, BerringtonG A, et al. Cervical cancerand use of hormonal contraceptives: a systematic review [J]. Lancet, 2003, 361: 1159-1167.
[31] Paer A, Bayatpour M, Paer MM, Oncogenic transformation of human papilloma virus type deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptive. Am J Obstet Gynecol, 1990, 162: 1009-103.
[32] Auborn KJ, Woodworth C, DiPaolo JA, Bradlow HL. The interaction between HPVestrogen metabolism in cervical carcinogensis.Int J Cancer 1991, 49: 857-67.
[33] Lassise DH, savitz DA, Hamman RF, Baron AE, Barnton LA, Levines RS. Invasion cervical cancer and intrauterine device use. Int J Epidemiol 1991, 20: 865-70.
[34]杜丽敏,王玉荣,陆春雪,洪春艳.性交后出血与病理学异常的关系探讨.中国实用妇科和产科杂志. 2003, 19(6): 343-344.
[35] deSouza NM, Soutter WP, McIndoe GA, et al. StageⅠcervical cancer:tumor volume by magnetic resonance imaging of screen-detected versus symptomatic lesions. J Natl Cancer Inst, 1997, 89: 131.
[36]高娜.传统巴氏涂片法、液基制片法及HPV-DNA检测法筛查宫颈癌及癌前病变的比较研究. 2004中国优秀硕士论文: 12-13.
[37] Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women·Br JCancer, 2001, 84: 1616-1623.
[38] Blumenthal PD, Gaffikin L, Chirenje ZM, et al. Adjunctive testingfor cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int Jgynaecol Obstet, 2001, 72: 47-53.
[39]杨钦灵.宫颈刮片联合人乳头瘤病毒检测在诊断子宫颈疾病中的应用,临床和实用医学杂志,2006, 5(9): 1281.
[40] Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papilloma virus testing, and risk for cervical neoplasia: a 10-year cohort analysis. JNatlCancer Inst, 2003, 95: 46-52.
[41] Schletcht. NF, Platt RW, Duarte E, et al. Human, papapilloma, virus infection and time to, progression and regression of cervical intraepithelia neoplasiaJ-Natl-Cancer-Ist, 2003, 95: 1336-1343.
[42] Agorastos T, Dinas K, Llove B, et al. Human papilloma-virus testing for primaryscreening in woman at low risk of developing cervical cancer [J]. Gynecolgic Oncology, 2005, 96(3): 714-720.
[43]牛淑芳,吴素慧.人乳头瘤病毒检测的研究进展[J].实用肿瘤学杂志, 2006, 82: 143-145.
[44]刘树范,冼美生,宫颈及阴道细胞病理学诊断报告方式的建议, Chin J Obstet Gynecl. May 1998. Vol 33. No 5:316.
[1] Douglas R, Lowy and John T, Schiller. Prophlactic human papilloma vaccines,The Journal of Clinical Investigation. 2006 May, 116(5): 1167-1173.
[2] Ftcutts S, Franceschi S, Goldie X, Castellsague, Sdesanjose, Ggarnett, Wjedmunds, P Claeys. Human Papillomavirus and HPV Vaccines, Bulletin of the World Health Organization. 2007 September, 85(9): 719-726.
[3] Bishop A, Sherris J, Tsu V. Cervical dysplasia treatmentpractices in developing countries: A situational analysis.Seattle(WA): Program for Appropriate Technology in Health (PATH), 1995.
[4] Wallboomers, JMM, Meijer, CHLM. Do, HPV-negative cervical carcinomasexist? J Pathol. 1997, 181: 253-254.
[5]王金桃,高尔生. HPV感染与宫颈癌关系研究进展,国外医学妇幼保健分册. 2003, 14(6): 399-403.
[6]詹姆斯,主编(James DK).高危妊娠处置的选择,第二版,北京科学出版社. 2001, 506.
[7] H.S.Cronje Screening for cervical cancer in developing countries, International Journal of Gynecology and Obstetrics 2004, 84: 101-108
[8] Carolyn D, Runowicz, M. D, Molecular Screening for Cervical Cancer time to Give up Pap Tests? The new Egland and journal of medicinen October, 2007(18): 1651-1652.
[9]刘树范,浅析巴氏五级分类法与TBS描述性诊断报告方式,中国实用妇科和产科杂志2003, 19(3): 135.
[10]沈艳红,乔友林.宫颈癌筛查方法的研究进展,国外医学情报, 2007, 22(7): 2-3, 14.
[11]潘秦镜,李凌,乔有林等.液基细胞学筛查宫颈癌的研究,中华肿瘤杂志. 2001, 23(4): 309-312.
[12] Aldx Ferenczy, Eduardo Franco, Cervical-cancer screenning beyond the year 2000,lancel oncol, 2001, 2: 27-32
[13]高琼,吴伟民,莫益欢,等.宫颈刮片、阴道镜及HPV检测在宫颈癌筛查中的体会,吉林医学2006, 27(7): 755.
[14]丁峰,丘娜璇,许雅云.宫颈涂片提示炎症963例与阴道镜下宫颈活检结果对比分析,福建医药杂志. 2005, 27(6): 24.
[15]田亚丽,于黎明,赵俊杰,等.宫颈病变检查413例临床分析,宁夏医学院学报,2008, 30(3): 333.
[16]杜丽敏,王玉荣,陆春雪,等.性交后出血与病理学异常的关系,探讨中国实用妇科和产科杂志, 2003, 19(6): 343-344.
[17] deSouza NM, Soutter WP, Mcndoe GA, et al. StageⅠcervical cancer tumor volume by magnetic resonance imaging of screen-detected versus symptomatic lesions, J Natl Cancer Inst, 1997, 89: 1314.
[18] Fraser IS, Petrucco OM. Management of intermenstrual and post-coital bleeding and an appreciation of the issues arising out of therecent case of O’shea versus Sullivan and Macqurie pathology. AustN Z J Obstet Gynecol. 1996, 36: 67.
[19]陈碧霞. 216例绝经后阴道出血原因分析,黔南民族医专学报. 2006, 19(4): 203-205.
[20]山东省人民医院,中国人民解放军九一医院,山东医学院附属医院主编,实用妇科学,山东科学技术出版社. 1980, 504.
[21] Castle, Philip E. Beyond human papillomavirus, the cervix, exogenous secondary factors, and the development of cervical precancer and cancer [J]. The American Society for Colposcopy and CervicalPathology. 2004, 8(3): 224-230.
[22]杜丽敏,陆春雪,赵巍.宫颈糜烂267例肉眼所见与病理诊断结果对比分析,中国现代医学杂志. 2006, 16(18): 2807-2808.
[23] Liu J, Rose B, Huang X, et al. Comparative analysis ofcharacteristics of women with cervical cancer in high-versus low-incidence regions [J]. GynecolOnco, 2004, 94(3): 803-810.
[24] Torres LA, Rojo HG, Torres RA, et al. Cervical cancer current view of its epidemiology and risk factors [J]. Gyneco lObstet Mex. 2004, 72: 466-474.
[25]连利娟.林巧稚妇科肿瘤学[M].第三版.北京:人民卫生出版社. 2000, 246-247.
[26] Velema JP, Ferrer A, Figueroa M, et al. Burning wood in the kitchen increasesthe risk of cervical neoplasia in HPV-infected women inHonduras [J]. Int JCancer, 2002, 97(4): 536-541.
[27]石一复.子宫颈疾病[M].北京:人民卫生出版社. 2000, 134-135.
[28] Smith JS, Green J, Berrington GA, et al. Cervical cancerand use of hormonal contraceptives: a systematic review [J]. Lancet, 2003, 361: 1159-1167.
[29] Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection, the IARC multicentric case control study [J]. Lancet, 2002, 359: 1085-1092.
[30]苑丹丹, HPV感染与宫颈癌相关研究进展.内蒙古医学杂志. 2007, 39(8): 957-960.
[31] Kevin A, Ault, Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract, infectious Diseasesin Obstetrics and Gynecology. 2006, 40470: 1-5.
[32] Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected,acase-control study nested within the Mancheste cohort, Br J Cancer. 2000, 88(11): 1565-1572.
[33] Georgette DA, TheresaFW, Human papillomavirua and cervical scereening, Curr Opin Obstet Gynecol. 2003, 15: 473-477.
[34]章文华主编.子宫颈病变的诊断要点,人民卫生出版社. 2006, 12(1).
[35] Oikawa K,Ohbayashi T, Kiyono T, et al. Expression of a novel human gene, human wings apart-like(Hwapl), is associated with cercical carcinogens antumor progression, Cancer Res. 2004, 64(5): 3545-3549.
[36]郎景和.迎接子宫癌预防的全球挑战与机遇,中华妇产科杂志. 2002, 37: 1291.